Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals (MDGL) , Corcept Therapeutics (CORT) , Catalyst Pharmaceuticals (CPRX) , Larimar Therapeutics (LRMR) and Theravance Biopharma (TBPH) .Industry: Small PharmaLink: https://www.zacks.com/commentary/2367138/5-small-drug-stocks-to-buy-as-trump-gets-re-elected?art_rec=quote-stock_overview-zacks_news-ID01-txt-2367138The drug industry witnessed major policy changes during Joe Biden's four-year term as U ...